Verified Nov 2026
Other
·

Greenfield, Indiana
·
Since 1954
Elanco is a global animal health pharmaceutical company headquartered in Greenfield, Indiana, founded in 1954. The company operates as an independent entity with approximately 9,450 employees and reported 2025 revenue of $4.715 billion. Elanco develops, manufactures, and markets health solutions for pets and livestock across more than 90 countries, including parasiticides, vaccines, therapeutics, medicated feed additives, and injectable antibiotics. In 2026, the company expanded its biologics manufacturing capacity at its Kansas facility.
Elanco at a glance
Revenue
$1-5B
Est. band
Employees
5,000-10,000
Founded
1954
Headquarters
Greenfield, Indiana
Import activity
2316
Industries
Automotive
Electric Vehicles
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
2316
Named foreign suppliers
33
Top origins
Germany · Israel · United Kingdom · Belgium

Shared foreign counterparties do not establish that these companies buy from Elanco.
What this tells a buyer
Elanco received 2,316 shipments across 16 origin countries, with major sourcing from Germany, Israel, and Switzerland; top suppliers included its own German-based operations with 858 shipments and Bayer Animal Health with 535 shipments.
The company offers parasiticides, vaccines, therapeutics, medicated feed additives, injectable antibiotics, insecticides, and enzymes for prevention and treatment of disease in pet and farm animals.
Elanco acquired AHV International in 2026 and entered a licensing agreement with Syngulon for expanded animal health capabilities.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
72 years in operation (founded 1954).
2,316 US import shipments on record.
Overview
Elanco is a global animal health pharmaceutical company headquartered in Greenfield, Indiana, founded in 1954. The company operates as an independent entity with approximately 9,450 employees and reported 2025 revenue of $4.715 billion. Elanco develops, manufactures, and markets health solutions for pets and livestock across more than 90 countries, including parasiticides, vaccines, therapeutics, medicated feed additives, and injectable antibiotics. In 2026, the company expanded its biologics manufacturing capacity at its Kansas facility.
At a glance
Attribute | Detail |
|---|---|
Founded | 1954 |
Headquarters | Greenfield, Indiana |
Employees | 5,000-10,000 |
Revenue | $1-5B (estimated) |
What Elanco makes
The company offers parasiticides, vaccines, therapeutics, medicated feed additives, injectable antibiotics, insecticides, and enzymes for prevention and treatment of disease in pet and farm animals.
Trade and customs footprint
Elanco received 2,316 shipments across 16 origin countries, with major sourcing from Germany, Israel, and Switzerland; top suppliers included its own German-based operations with 858 shipments and Bayer Animal Health with 535 shipments. US customs bill-of-lading records list 2316 inbound shipments across 33 foreign suppliers, with top origins including Germany · Israel · United Kingdom · Belgium.
Latest developments
2026-10-06 — One Health Innovation District Breaks Ground (elanco.com)
2026-08-26 — Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility | Wed, 08/26/2026 - 08:30 (elanco.com)
2026-05-21 — Matheson advises Elanco Animal Health on its acquisition of AHV International | Experiences | Matheson (matheson.com)
2026-03-27 — Syngulon announces licensing agreement with Elanco Animal Health (biopark.be)
2025-12-10 — Elanco Announces Investment in U.S. Manufacturing and R&D (elanco.com)
2025-12-09 — Elanco Investor Day Defines New Era as Sustainable Growth Company (elanco.com)
Facilities
Elanco is headquartered in Greenfield, Indiana. Public sources also reference these locations:
Elwood, Kansas — elanco.com
Company details
Elanco acquired AHV International in 2026 and entered a licensing agreement with Syngulon for expanded animal health capabilities. Elanco was founded in 1954, has an estimated 5,000-10,000 employees, and is headquartered in Greenfield, Indiana. On the LightSource stability read it is rated "Established & active": 72 years in operation (founded 1954). 2,316 US import shipments on record.
Frequently asked questions
What does Elanco do?
Elanco is a global animal health pharmaceutical company headquartered in Greenfield, Indiana, founded in 1954. The company operates as an independent entity with approximately 9,450 employees and reported 2025 revenue of $4.715 billion. Elanco develops, manufactures, and markets health solutions for pets and livestock across more than 90 countries, including parasiticides, vaccines, therapeutics, medicated feed additives, and injectable antibiotics. In 2026, the company expanded its biologics manufacturing capacity at its Kansas facility.
Where is Elanco headquartered?
Elanco is headquartered in Greenfield, Indiana (2500 Innovation Way, Greenfield, Indiana, 46140).
When was Elanco founded?
Elanco was founded in 1954.
How big is Elanco?
Elanco has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).
Does Elanco import from overseas suppliers?
US customs bill-of-lading records show 2316 inbound shipments for Elanco, with top origins including Germany · Israel · United Kingdom · Belgium.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
